Impact of a High Saturated Fat Diet on Fasted Systemic and White Adipose Tissue Inflammatory Responses

January 3, 2019 updated by: Dr Oonagh Markey, Loughborough University

Impact of Short-term Overfeeding With a Saturated Fat-rich Diet on Fasted Systemic and White Adipose Tissue Inflammatory Responses

This study will investigate the effect of a 7-day westernised high-fat (65% of kilocalories), high-calorie (150% of requirements) diet on markers of inflammation in the blood and white adipose tissue. Participants will firstly complete a 3-day weight maintenance phase (Days 1-3) before completing a 7-day high fat diet intervention (Days 4-10). On days 4 and 11 participants will complete a laboratory visit where anthropometric measurements, blood and adipose samples will be collected.

The investigators hypothesise that consuming a high-fat, high-calorie diet for 7 days will alter the inflammatory responses in white adipose tissue and will induce metabolic endotoxaemia / systemic inflammation.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Leicestershire
      • Loughborough, Leicestershire, United Kingdom, LE11 3TU
        • Loughborough University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion criteria:

  • 18-40 years
  • BMI = 21.0-29.9 kg/m2
  • Male or female
  • Physically active (> 3 x 30 min moderate exercise per week)
  • Healthy
  • No cardiometabolic (e.g. heart disease, high blood pressure, type 2 diabetes) or inflammatory illness

Exclusion criteria:

  • Inactive (< 3 x 30 min moderate exercise per week)
  • Smoker
  • Women who are pregnant or lactating
  • Medication/supplements known to interfere with study outcomes or prescribed antibiotics within the last 3 months
  • Unstable weight history (≥3kg loss or gain in the previous 3 months)
  • An allergy to lidocaine
  • Food allergies (e.g. gluten, dairy) and intolerances (e.g. lactose) which could impede compliance to the diet
  • Vegetarian/ vegan (as the high-fat diet is based on animal fats)
  • Consumption of probiotics yogurts during or within the four weeks prior to the start of the study (e.g. Actimel, Activia, Yakult, Yeo Valley)
  • Alcohol consumption >28 units per week for a man (i.e. not more than 14 pints of beer or 28 small glasses of wine) or >21 units per week for a woman (i.e. more than 10 and a half pints of beer or 21 small glasses of wine)
  • Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention or metabolic study
  • Restrained eaters (determined by Three Factor Eating Questionnaire)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: High Fat Diet
Participants will consume a high-fat, high-calorie diet for 7 days (i.e. westernised diet) following a 3-day weight maintenance diet. Measurements will be made pre- and post-high fat diet intervention.

Participants will consume a high fat diet for 7 days with 65% of energy from fat. The diet will also provide an energy excess at 150% of energy requirements.

Participants will be provided with all of their meals and snacks throughout the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protein expression (content and phosphorylation) of key markers of metabolic inflammation in white adipose tissue (for example assessment of NFKB/IKBa total protein and phosphorylation by western blot analysis)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
This will be assessed following the collection of fasted white adipose tissue samples
Change between pre- and post-high fat diet (assessed on days 4 and 11)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Systemic Markers of Inflammation (for example CRP, TNFa and IL-6 concentrations, determined by spectrophotometric assay/ ELISA)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
Assessed following the collection of fasted blood samples
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Gene expression of key markers of metabolic inflammation in white adipose tissue
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
This will be assessed following the collection of fasted white adipose tissue samples
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Fasting Serum Markers of Insulin Resistance (for example insulin and glucose concentrations, determined using an ELISA/ spectrophotometric assay)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
Assessed following the collection of fasted blood samples
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Fasting Serum Lipid Profile (for example total, HDL and LDL cholesterol, TAG and NEFA concentrations, measured using a spectrophotometric assay)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
Assessed following the collection of fasted blood samples
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Systemic Markers of Metabolic Endotoxemia (for example LBP and sCD14 concentrations, determined using an ELISA)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
Assessed following the collection of fasted blood samples
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Immune Cell Populations in the Blood
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
Assessed following the collection of fasted blood samples
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Anthropometric Measurements (for example height and weight that will be aggregated to report BMI in kg/m^2)
Time Frame: Change between pre- and post-high fat diet (assessed on days 4 and 11)
Measured using standard equipment
Change between pre- and post-high fat diet (assessed on days 4 and 11)
Physical Activity
Time Frame: Habitual physical activity will be assessed for 3 days prior to commencing the high-fat diet intervention (days 1-3) and during the final 3 days of the intervention (days 8-10)
Assessed using Actigraph accelerometers
Habitual physical activity will be assessed for 3 days prior to commencing the high-fat diet intervention (days 1-3) and during the final 3 days of the intervention (days 8-10)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 2, 2018

Primary Completion (ACTUAL)

November 23, 2018

Study Completion (ACTUAL)

November 23, 2018

Study Registration Dates

First Submitted

May 22, 2018

First Submitted That Met QC Criteria

June 14, 2018

First Posted (ACTUAL)

June 26, 2018

Study Record Updates

Last Update Posted (ACTUAL)

January 4, 2019

Last Update Submitted That Met QC Criteria

January 3, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • R18-P040

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on High Fat Diet

3
Subscribe